Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors

Medical and Pediatric Oncology

Volumn 29, Issue 1, 1997, Pages 28-32

  Needle, M N ^a   Molloy, P T ^a   Geyer, J R ^a   Herman Liu, A ^a   Belasco, J B ^a   Goldwein, J W ^a   Sutton, L ^a   Phillips, P C ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

brain tumor; children; ependymoma; etoposide; glioma; medulloblastoma

Indexed keywords

DNA TOPOISOMERASE; ETOPOSIDE;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CROSS LINKING; DIARRHEA; DISEASE COURSE; EPENDYMOMA; FEMALE; FEVER; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEDULLOBLASTOMA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0030947999     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199707)29:1<28::AID-MPO5>3.0.CO;2-U     Document Type: Article

References (21)